+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Closed System Drug-Transfer Device Market - Global Forecast 2026-2032- Product Image
Closed System Drug-Transfer Device Market - Global Forecast 2026-2032- Product Image
Sale

Closed System Drug-Transfer Device Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6158188
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Closed-System Drug-Transfer Devices: Executive Overview

Closed-system drug-transfer devices (CSTDs) are engineered to reduce the escape of hazardous drugs and drug vapors during preparation, transfer, administration, and disposal. Their relevance is closely tied to occupational exposure controls in oncology, pharmacy compounding, hospital medication workflows, and other settings handling hazardous pharmaceuticals. Adoption decisions typically reflect safety requirements, workflow compatibility, training needs, procurement standards, and alignment with institutional medication-management policies.

Safety Standards and Workflow Integration Are Reshaping Adoption

The landscape is shifting from isolated device purchases toward integrated hazardous-drug handling programs. Health systems increasingly assess vial access, syringe connection, transfer, administration, waste handling, cleaning, and staff training as one connected process. Regulatory guidance, professional standards, employer safety duties, and heightened attention to exposure prevention are encouraging more consistent controls. Devices that support intuitive operation, compatibility with existing pharmacy and nursing workflows, reliable containment, and practical decontamination are better positioned to address implementation barriers.

Artificial Intelligence Strengthens Risk Control and Operational Discipline

Artificial intelligence can support this market indirectly by improving medication workflow monitoring, identifying process deviations, optimizing inventory and scheduling, and helping organizations target training or audit activity. Computer-vision and sensor-enabled systems may eventually assist with verification of connection steps, spill detection, and adherence documentation, subject to validation and privacy requirements. AI does not replace physical containment: its value depends on integration with validated devices, human oversight, cybersecurity controls, and evidence that alerts improve safety without adding operational complexity.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally emphasizes formal hazardous-drug handling programs, institutional procurement criteria, and occupational exposure controls. Europe places strong weight on worker protection, standardized clinical practice, and compatibility with national and European regulatory frameworks. Asia-Pacific combines advanced hospital adoption in several mature systems with expanding capacity, training, and infrastructure needs elsewhere. Latin America is shaped by uneven access to specialized pharmacy services, public and private health-system differences, and the need for cost-conscious implementation. The Middle East is influenced by centralized hospital development, specialty-care investment, and workforce training, while Africa presents varied readiness, with priorities centered on oncology capacity, basic pharmacy infrastructure, supply continuity, and practical staff protection.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Highlight Different Coordination Needs

ASEAN markets often require adaptable implementation models that account for diverse healthcare systems, procurement structures, and workforce capabilities. BRICS members span substantial differences in manufacturing, clinical infrastructure, and regulatory maturity, making harmonized safety principles important but locally tailored execution essential. The European Union benefits from cross-border regulatory coordination and occupational-health alignment. G7 systems generally have more established institutional controls and evidence-based procurement processes. GCC countries frequently combine centralized purchasing with rapidly developing tertiary-care capacity, while NATO members may share strong expectations around operational resilience, workforce protection, and continuity of medical supply and training systems.

Country-Level Conditions Shape Procurement, Training, and Implementation

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States commonly evaluate CSTDs within mature hospital safety, pharmacy, and occupational-health frameworks, although local guidance, reimbursement, procurement, and workflow requirements differ. China and India combine expanding oncology and hospital capacity with substantial variation among provinces, institutions, and care settings. Brazil, Mexico, and Russia likewise reflect differences in public and private provision, regulatory execution, distribution, and access to trained compounding personnel. Across all listed countries, successful implementation depends on compatibility with local medication systems, validated staff training, dependable supply and servicing, and clear monitoring of handling practices.

Prioritize Validated Workflows, Training, and Evidence-Based Procurement

Industry leaders should map the complete hazardous-drug pathway before selecting a device, then test usability with pharmacists, nurses, technicians, and waste-handling staff. Procurement criteria should cover containment performance, compatibility with commonly used containers and administration systems, failure modes, cleaning and disposal, supply continuity, documentation, and total implementation burden. Organizations should establish competency-based training, periodic observation, incident reporting, and continuous improvement measures. Suppliers and care providers should also generate transparent, independently reviewable evidence, support interoperability where appropriate, and tailor deployment plans to regional infrastructure and regulatory expectations.

Research Methodology: Evidence-Led Executive Synthesis

This executive summary uses the supplied market definition-closed-system drug-transfer devices-and organizes verified industry considerations around occupational exposure prevention, hazardous-drug handling, clinical workflow integration, regional healthcare conditions, and technology-enabled operations. Insights are framed qualitatively and avoid market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country narratives synthesize differences in healthcare infrastructure, regulatory context, procurement practice, workforce capability, and implementation readiness; conclusions should be validated against current jurisdiction-specific standards and institutional evidence before operational decisions are made.

CSTDs Become Most Valuable When Embedded in a Complete Safety System

The strategic role of closed-system drug-transfer devices extends beyond the hardware itself. Their contribution is strongest when physical containment is combined with standardized procedures, competent personnel, compatible medication workflows, effective waste controls, and continuous auditing. Regional and country differences require flexible deployment, while AI and digital tools can improve oversight when carefully validated. Leaders should therefore treat CSTD adoption as part of an organization-wide hazardous-drug safety program rather than as a standalone equipment decision.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Closed System Drug-Transfer Device Market, by Device Type
7.1. Introduction
7.2. Bag Access Systems
7.3. Syringe Based Systems
7.4. Vial Access Systems
8. Closed System Drug-Transfer Device Market, by Component
8.1. Introduction
8.2. Clamps
8.3. Needleless Connectors
8.4. Tubing
8.5. Valves
9. Closed System Drug-Transfer Device Market, by Drug Type
9.1. Introduction
9.2. Biologic
9.3. Cytotoxic
9.4. Small Molecule
10. Closed System Drug-Transfer Device Market, by Application
10.1. Introduction
10.2. General Purpose Compounding
10.3. Oncology
10.4. Parenteral Nutrition
11. Closed System Drug-Transfer Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Home Healthcare
11.5. Hospitals
12. Closed System Drug-Transfer Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Closed System Drug-Transfer Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Closed System Drug-Transfer Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. B. Braun Melsungen AG
16.2. Baxter International Inc.
16.3. Becton, Dickinson and Company
16.4. Caragen Ltd.
16.5. Cardinal Health
16.6. CODAN Medizinische Geräte GmbH & Co. KG
16.7. Corning Incorporated
16.8. Corvida Medical
16.9. Epic Medical
16.10. EQUASHIELD LLC
16.11. ICU Medical, Inc.
16.12. JMS Co., Ltd.
16.13. Simplivia Healthcare Ltd.
16.14. Terumo Corporation
16.15. Vygon SA
16.16. West Pharmaceutical Services, Inc.
16.17. Yukon Medical, LLC
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Closed System Drug-Transfer Device Market, Years Considered for the Study
FIGURE 2. Global Closed System Drug-Transfer Device Market, Research Design
FIGURE 3. Global Closed System Drug-Transfer Device Market, Research Framework
FIGURE 4. Global Closed System Drug-Transfer Device Market, Data Triangulation
FIGURE 5. Global Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Closed System Drug-Transfer Device Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 7. Global Closed System Drug-Transfer Device Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Closed System Drug-Transfer Device Market Size, by Component, 2025 vs 2032 (%)
FIGURE 9. Global Closed System Drug-Transfer Device Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Closed System Drug-Transfer Device Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 11. Global Closed System Drug-Transfer Device Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Closed System Drug-Transfer Device Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Closed System Drug-Transfer Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Closed System Drug-Transfer Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Closed System Drug-Transfer Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Closed System Drug-Transfer Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Closed System Drug-Transfer Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Closed System Drug-Transfer Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Closed System Drug-Transfer Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Closed System Drug-Transfer Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Closed System Drug-Transfer Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Closed System Drug-Transfer Device Market Segmentation & Coverage
TABLE 2. Global Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 4. Global Bag Access Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bag Access Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bag Access Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Syringe Based Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Syringe Based Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Syringe Based Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Vial Access Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Vial Access Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Vial Access Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 14. Global Clamps Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Clamps Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Clamps Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Needleless Connectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Needleless Connectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Needleless Connectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tubing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tubing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tubing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 27. Global Biologic Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Biologic Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Biologic Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Cytotoxic Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Cytotoxic Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Cytotoxic Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Small Molecule Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Small Molecule Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Small Molecule Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global General Purpose Compounding Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global General Purpose Compounding Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global General Purpose Compounding Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Parenteral Nutrition Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Parenteral Nutrition Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Parenteral Nutrition Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. North America Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 68. North America Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 69. North America Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 70. North America Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. North America Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Latin America Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 74. Latin America Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 75. Latin America Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 76. Latin America Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Latin America Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Europe Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 80. Europe Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 81. Europe Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 82. Europe Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Europe Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Middle East Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Middle East Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 86. Middle East Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 87. Middle East Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 88. Middle East Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Middle East Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Africa Closed System Drug-Transfer Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Africa Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 92. Africa Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 93. Africa Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 94. Africa Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Africa Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 99. ASEAN Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 100. ASEAN Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 101. ASEAN Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. ASEAN Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. GCC Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. GCC Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 105. GCC Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 106. GCC Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 107. GCC Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. GCC Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. European Union Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 111. European Union Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 112. European Union Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 113. European Union Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. European Union Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. BRICS Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 117. BRICS Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 118. BRICS Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 119. BRICS Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. BRICS Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. G7 Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. G7 Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 123. G7 Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 124. G7 Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 125. G7 Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. G7 Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. NATO Closed System Drug-Transfer Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 129. NATO Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 130. NATO Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 131. NATO Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. NATO Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Global Closed System Drug-Transfer Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. United States Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 135. United States Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 136. United States Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 137. United States Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 138. United States Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. United States Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Canada Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 141. Canada Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 142. Canada Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 143. Canada Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 144. Canada Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Canada Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Mexico Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 147. Mexico Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 148. Mexico Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 149. Mexico Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 150. Mexico Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Mexico Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Brazil Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 153. Brazil Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 154. Brazil Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 155. Brazil Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 156. Brazil Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Brazil Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. United Kingdom Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 159. United Kingdom Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 160. United Kingdom Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 161. United Kingdom Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 162. United Kingdom Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. United Kingdom Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Germany Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 165. Germany Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 166. Germany Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 167. Germany Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 168. Germany Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Germany Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. France Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 171. France Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 172. France Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 173. France Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 174. France Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. France Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Russia Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 177. Russia Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 178. Russia Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 179. Russia Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 180. Russia Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Russia Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Italy Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 183. Italy Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 184. Italy Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 185. Italy Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 186. Italy Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Italy Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Spain Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 189. Spain Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 190. Spain Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 191. Spain Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 192. Spain Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Spain Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. China Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 195. China Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 196. China Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 197. China Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 198. China Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. China Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. India Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 201. India Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 202. India Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 203. India Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 204. India Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. India Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Japan Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 207. Japan Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 208. Japan Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 209. Japan Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 210. Japan Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Japan Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Australia Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 213. Australia Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 214. Australia Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 215. Australia Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 216. Australia Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Australia Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. South Korea Closed System Drug-Transfer Device Market Size, 2017-2032 (USD Million)
TABLE 219. South Korea Closed System Drug-Transfer Device Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 220. South Korea Closed System Drug-Transfer Device Market Size, by Component, 2017-2032 (USD Million)
TABLE 221. South Korea Closed System Drug-Transfer Device Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 222. South Korea Closed System Drug-Transfer Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. South Korea Closed System Drug-Transfer Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Global Closed System Drug-Transfer Device Market Share, by Key Player, 2025
TABLE 225. Global Closed System Drug-Transfer Device Market, Key Experts

Companies Mentioned

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caragen Ltd.
  • Cardinal Health
  • CODAN Medizinische Geräte GmbH & Co. KG
  • Corning Incorporated
  • Corvida Medical
  • Epic Medical
  • EQUASHIELD LLC
  • ICU Medical, Inc.
  • JMS Co., Ltd.
  • Simplivia Healthcare Ltd.
  • Terumo Corporation
  • Vygon SA
  • West Pharmaceutical Services, Inc.
  • Yukon Medical, LLC

Related Topics

Related Reports

Needle-free Closed System Transfer Equipment Market - Global Forecast 2026-2032 - Product Image

Needle-free Closed System Transfer Equipment Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Cavity Injection Layer Material Market - Global Forecast 2026-2032 - Product Image

Cavity Injection Layer Material Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Vial Adaptors for Drug Reconstitution - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Vial Adaptors for Drug Reconstitution - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Global Intravenous (IV) Equipment Market Outlook, 2031 - Product Image

Global Intravenous (IV) Equipment Market Outlook, 2031

  • Report
  • 190 Pages
  • Global
From
Europe Intravenous (IV) Equipment Market Outlook, 2031 - Product Image

Europe Intravenous (IV) Equipment Market Outlook, 2031

  • Report
  • 94 Pages
  • Europe
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.